Martin Nutraceuticals Inc. (PINKSHEETS: MNCL) is finalizing an agreement for distribution rights for the treatment
of male testosterone deficiency.
To read the complete release, go to
http://biz.yahoo.com/bw/070222/20070222005973.html?.v=1
For a Free Newsletter, go to http://www.OTCReporter.com
Other active stocks are Applied Materials, Inc. (NASDAQ: AMAT), Charter
Communications, Inc. (NASDAQ: CHTR) and Nitches, Inc. (NASDAQ: NICH).
Information, opinions and analysis contained herein are based on sources
believed to be reliable, but no representation, expressed or implied, is
made as to its accuracy, completeness or correctness. The opinions
contained herein reflect our current judgment and are subject to change
without notice. We accept no liability for any losses arising from an
investor's reliance on or use of this report. This report is for
information purposes only, and is neither a solicitation to buy nor an
offer to sell securities. A Third Party has hired and paid $500.00 for the
publication and circulation of this report. Certain information included
herein is forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995, including, but not limited to, statements
concerning manufacturing, marketing, growth, and expansion. Such
forward-looking information involves important risks and uncertainties that
could affect actual results and cause them to differ materially from
expectations expressed herein. We have no ownership of equity, no
representation, do no trading of any kind and send No Faxes or Emails to
promote stocks.